Federal award · other reimbursable, contingent, intangible, or indirect financial assistance
"COVID-19" Technology Investment Agreement (32 CFR Part 37) Domestic Industrial Base Expansion- Advanced Manufacturing Validation and Domestic Industrial Base Capacity Expansion of Advanced, High-quality Valor Glass Tubing and Vials/cartridges to Reduce Supply Chain Risk and Ensure Rapid Delivery of Medical Countermeasures (MCMS) to the Warfighter and MCMS and Other Supportive Therapies to Protect U.s. Public Health in Response to the COVID-19 Pandemic and Other Future Public Health Emergencies
Committed
$231.4 Million
Everything here is this single award's whole record — signed, amended, paid — not a fiscal-year slice. The by-year charts elsewhere split an award across the years it was committed; this page keeps it whole.
Committed is what the government has legally promised on this award so far. Contracts can also carry a ceiling — the maximum if every option is exercised. Unspent ceiling is headroom, not money owed.
The cash actually disbursed against this award. The gap from committed is the disbursement pipeline: promised, not yet cashed.
Each transaction is a signing event — an action that created or changed the award, dated the day it was signed — not a payment. Negative amounts are real: money de-committed at closeout or renegotiation.
One bar, the award’s whole arithmetic: paid out, then committed, not yet paid, then .
Loading…